287 related articles for article (PubMed ID: 11023538)
21. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
22. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
Yadav U; Kumar P; Rai V
Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
[TBL] [Abstract][Full Text] [Related]
23. The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer.
Gorący J; Bogacz A; Uzar I; Wolek M; Łochyńska M; Ziętek P; Czerny B; Cymbaluk-Płoska A; Modliborski P; Kamiński A
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356648
[TBL] [Abstract][Full Text] [Related]
24. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects.
Niwa Y; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K; Hamajima N
Gynecol Oncol; 2005 Feb; 96(2):423-9. PubMed ID: 15661231
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
Li C; Liu Y; Wei S; Zhou Y
Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
[TBL] [Abstract][Full Text] [Related]
26. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke.
Shyu HY; Fong CS; Fu YP; Shieh JC; Yin JH; Chang CY; Wang HW; Cheng CW
Clin Chim Acta; 2010 Jun; 411(11-12):840-5. PubMed ID: 20193673
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
[TBL] [Abstract][Full Text] [Related]
28. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
[TBL] [Abstract][Full Text] [Related]
29. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
[TBL] [Abstract][Full Text] [Related]
30. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of K ras mutations in Pakistani colorectal cancer patients.
Murtaza BN; Bibi A; Rashid MU; Khan YI; Chaudri MS; Shakoori AR
Braz J Med Biol Res; 2014 Jan; 47(1):35-41. PubMed ID: 24519090
[TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
Siegel D; McGuinness SM; Winski SL; Ross D
Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
[TBL] [Abstract][Full Text] [Related]
34. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
[TBL] [Abstract][Full Text] [Related]
36. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
[TBL] [Abstract][Full Text] [Related]
37. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
Liu Y; Zhang D
Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
[TBL] [Abstract][Full Text] [Related]
38. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.
Lewis SJ; Cherry NM; Niven RM; Barber PV; Povey AC
Lung Cancer; 2001 Nov; 34(2):177-83. PubMed ID: 11679176
[TBL] [Abstract][Full Text] [Related]
40. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]